CE Marking - QCS International

part of the phsc group

CE Marking

There are many routes open to achieving a CE mark for a medical device. Factors that influence the route include the classification of the device, the costs involved in clinical investigation or clinical evaluation and the intended use of the device.

QCS can assist in the development of trials, programmes and activities that are required to meet CE Certification requirements as required by the European medical devices directive.

This includes advice on ISO 13485 (and determining if compliance is a requirement) and encompasses the necessary aspects of Management Responsibility, Resource Management, Product Realisation and Measurement, analysis and improvement. Recent changes in the standard ensure that any requirements not applicable to the organisation can be excluded from the scope of their ISO 13485 certification, allowing the standard to be applied more easily to organisations.

We also provide product specific support in relation to preparation of technical files, design and development files and post market surveillance plans to meet statutory vigilance requirements.

We have consultants with experience in all phases of the product development life-cycle, so whether you intend to CE mark a new product or are continually improving your existing products to keep up with ever more stringent regulatory requirements, QCS can provide the expertise you require in:

  • Identifying the required technical documentation and applicable standards
  • Validation of processes used in development and manufacture
  • Ensuring critical suppliers and processes are identified and controlled
  • Ensuring Risk Management processes meet the requirements of applicable standards (including ISO 14971)
  • Verifying labelling and information supplied to users meets the required standard
  • Assistance in dealing with Notified Bodies


Call us to discuss your needs and to have someone visit to prepare a quotation.
01236 734447

QCS consultants have experience liaising with the MHRA in relation to ensuring that the Annex 10 requirements of the European Medical Device directives are met for the clinical evaluation of your design for validation.